Cargando…

Construction of SHIVs expressing quaternary neutralization epitopes in Env and mimicking the neutralization phenotype of typical HIV-1 isolates

Detalles Bibliográficos
Autores principales:	Theis, JF, de Parseval, A, Honnen, WJ, Phogat, A, Ganapathi, UC, Lai, Z, Peng, L, Reichman, C, Moore, PL, Morris, L, Li, Y, Hu, S, Pinter, A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3441856/ http://dx.doi.org/10.1186/1742-4690-9-S2-P28

Ejemplares similares

Structural dynamics reveal isolate-specific differences at neutralization epitopes on HIV Env
por: Hodge, Edgar A., et al.
Publicado: (2022)

SHIVs, monkeys, and anti-HIV-1 neutralizing antibodies
por: Martin, Malcolm A
Publicado: (2013)

Pre-existing neutralizing antibody mitigates B cell dysregulation and enhances the Env-specific antibody response in SHIV-infected rhesus macaques
por: Jaworski, Juan Pablo, et al.
Publicado: (2017)

Mapping Neutralizing Antibody Epitope Specificities to an HIV Env Trimer in Immunized and in Infected Rhesus Macaques
por: Zhao, Fangzhu, et al.
Publicado: (2020)

Antibodies to a conformational epitope on gp41 neutralize HIV-1 by destabilizing the Env spike
por: Lee, Jeong Hyun, et al.
Publicado: (2015)

Human Antibodies that Recognize Novel Immunodominant Quaternary Epitopes on the HIV-1 Env Protein
por: Hicar, Mark D., et al.
Publicado: (2016)

Characterization of V1V2-specific antibodies present in broadly neutralizing plasma isolated from HIV-1 infected individuals
por: Krachmarov, C, et al.
Publicado: (2012)

R5 Clade C SHIV Strains with Tier 1 or 2 Neutralization Sensitivity: Tools to Dissect Env Evolution and to Develop AIDS Vaccines in Primate Models
por: Siddappa, Nagadenahalli B., et al.
Publicado: (2010)

Differential binding of neutralizing and non-neutralizing antibodies to native-like soluble HIV-1 Env trimers, uncleaved Env proteins, and monomeric subunits
por: Yasmeen, Anila, et al.
Publicado: (2014)

Characterization of V1/V2-specific antibodies present in broadly neutralizing plasma isolated from HIV-1 infected individuals
por: Krachmarov, C, et al.
Publicado: (2012)

Human dengue virus serotype 2 neutralizing antibodies target two distinct quaternary epitopes
por: Gallichotte, Emily N., et al.
Publicado: (2018)

Antibody elicited by HIV-1 immunogen vaccination in macaques displaces Env fusion peptide and destroys a neutralizing epitope
por: Abernathy, Morgan E., et al.
Publicado: (2021)

Design of an HIV Env antigen that binds with high affinity to antibodies against linear, conformational and broadly neutralizing epitopes within V1/V2
por: Liao, L, et al.
Publicado: (2012)

Transplantation of a quaternary structure neutralizing antibody epitope from dengue virus serotype 3 into serotype 4
por: Widman, Douglas G., et al.
Publicado: (2017)

Neutralizing antibodies elicited in rabbits by patient-derived Env trimer immunization
por: Heyndrickx, L, et al.
Publicado: (2012)

A New Quaternary Structure Epitope on Dengue Virus Serotype 2 Is the Target of Durable Type-Specific Neutralizing Antibodies
por: Gallichotte, E. N., et al.
Publicado: (2015)

Limited SHIV env diversification in macaques failing oral antiretroviral pre-exposure prophylaxis
por: Zheng, Qi, et al.
Publicado: (2012)

A Next-Generation Cleaved, Soluble HIV-1 Env Trimer, BG505 SOSIP.664 gp140, Expresses Multiple Epitopes for Broadly Neutralizing but Not Non-Neutralizing Antibodies
por: Sanders, Rogier W., et al.
Publicado: (2013)

Neonatal SHIV infection in rhesus macaques elicited heterologous HIV-1-neutralizing antibodies
por: Hora, Bhavna, et al.
Publicado: (2023)

Passive neutralizing antibody controls SHIV viremia and enhances B cell responses in infant macaques
por: Ng, Cherie T., et al.
Publicado: (2010)

Specific Substitutions in Region V2 of gp120 env confer SHIV Neutralisation Resistance
por: Pisil, Yalcin, et al.
Publicado: (2020)

P04-09. Induction of cross-clade neutralizing antibodies with a prime/boost vaccine strategy focused on a neutralizing epitope
por: Zolla-Pazner, S, et al.
Publicado: (2009)

T cell-inducing vaccine durably prevents mucosal SHIV infection even with lower neutralizing antibody titers
por: Arunachalam, Prabhu S., et al.
Publicado: (2020)

Early short-term treatment with neutralizing human monoclonal antibodies halts SHIV infection in newborn macaques
por: Hessell, Ann J., et al.
Publicado: (2016)

Escape of Hepatitis C Virus from Epitope I Neutralization Increases Sensitivity of Other Neutralization Epitopes
por: Gu, Jun, et al.
Publicado: (2018)

Proteins mimicking epitope of HIV-1 virus neutralizing antibody induce virus-neutralizing sera in mice
por: Kosztyu, Petr, et al.
Publicado: (2019)

P04-51 LB. The epitopes of two newly identified broad and potent neutralizing antibodies, PG9 and PG16
por: Walker, L, et al.
Publicado: (2009)

Therapeutic Efficacy of Potent Neutralizing HIV-1-Specific Monoclonal Antibodies in SHIV-Infected Rhesus Monkeys
por: Barouch, Dan H., et al.
Publicado: (2013)

Improved delivery of broadly neutralizing antibodies by nanocapsules suppresses SHIV infection in the CNS of infant rhesus macaques
por: Wen, Jing, et al.
Publicado: (2021)

Maternal HIV-1 Env Vaccination for Systemic and Breast Milk Immunity To Prevent Oral SHIV Acquisition in Infant Macaques
por: Eudailey, Joshua A., et al.
Publicado: (2018)

High-resolution crystal structure of the Fv of quaternary neutralizing epitope mAb 2909 reveals atomic details of its antigen-binding site
por: Sampson, JM, et al.
Publicado: (2012)

Conformational Masking and Receptor-Dependent Unmasking of Highly Conserved Env Epitopes Recognized by Non-Neutralizing Antibodies That Mediate Potent ADCC against HIV-1
por: Lewis, George K., et al.
Publicado: (2015)

Recognition and penetration of the HIV-1 Env glycan shield by potent broadly neutralizing antibodies
por: Julien, J, et al.
Publicado: (2012)

An Efficiently Cleaved HIV-1 Clade C Env Selectively Binds to Neutralizing Antibodies
por: Boliar, Saikat, et al.
Publicado: (2015)

Panels of HIV-1 Subtype C Env Reference Strains for Standardized Neutralization Assessments
por: Hraber, Peter, et al.
Publicado: (2017)

Characterizing the Relationship Between Neutralization Sensitivity and env Gene Diversity During ART Suppression
por: Wilson, Andrew, et al.
Publicado: (2021)

HIV-2 Neutralization Sensitivity in Relation to Co-Receptor Entry Pathways and Env Motifs
por: Szojka, Zsófia Ilona, et al.
Publicado: (2022)

Broadly Neutralizing Human Anti-HIV Antibody 2G12 Is Effective in Protection against Mucosal SHIV Challenge Even at Low Serum Neutralizing Titers
por: Hessell, Ann J., et al.
Publicado: (2009)

Computational Prediction of Neutralization Epitopes Targeted by Human Anti-V3 HIV Monoclonal Antibodies
por: Shmelkov, Evgeny, et al.
Publicado: (2014)

Protective neutralizing epitopes in SARS‐CoV‐2
por: Liu, Hejun, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vjfungaaah0op3oi0ii44r8ans